https://doi.org/10.4081/reumatismo.2020.1297
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab
Submitted: 11 May 2020
Accepted: 18 July 2020
Published: 19 November 2020
Accepted: 18 July 2020
Abstract Views: 1045
PDF: 641
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
In this manuscript we aim to describe a particular case of a 63 years-old man who developed three different malignancies (one was a rare case of breast cancer) among nearly five years. In particular, for the diagnosis of melanoma, he was treated with pembrolizumab, a PD-1 inhibitor. After few months of treatment with pembrolizumab, the patient reported the onset of musculoskeletal symptoms such as inflammatory pain at the shoulders and morning stiffness, with raised CRP and ESR and imaging evidence of bursitis and tenosynovitis. A polymyalgia-like syndrome was diagnosed. Understanding if these manifestations are linked to the use of pembrolizumab or to a paraneoplastic syndrome, and how to manage the patient, was the real challenge.
How to Cite
Perrotta, F., Scriffignano, S., Fatica, M., Specchia, M., & Lubrano, E. (2020). Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab. Reumatismo, 72(3), 178–181. https://doi.org/10.4081/reumatismo.2020.1297
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- F. Macaluso, G. Guggino, A. Rizzo, A. Ferrante, F. Ciccia, Histopathology of the gut in rheumatic diseases , Reumatismo: Vol. 70 No. 3 (2018): Monographic issue on Histopathology in Rheumatic Diseases
- C. Perricone, R. Dal Pozzolo, G. Cafaro, S. Calvacchi, L. Bruno, F. Tromby, A. Colangelo, R. Gerli, E. Bartoloni, Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review , Reumatismo: Early Access
- U. Fiocco, S. Bombardieri, Differences in pharmacology of tumor necrosis factor (TNF) antagonists , Reumatismo: Vol. 57 No. s4 (2005)
- M.A. Cimmino, Magnetic resonance imaging of the joints: a revolution for the practicing rheumatologist , Reumatismo: Vol. 60 No. 4 (2008)
- G. El Hasbani, J. E Nassar, A.M. Elsayed Ali, I. Uthman, A. Jawad, The impact of nicotine smoking on spondyloarthritis and rheumatoid arthritis , Reumatismo: Vol. 76 No. 2 (2024)
- T. Borges, A. Barbosa, S. Silva, Adult-onset systemic autoinflammatory disorders: a clinical approach , Reumatismo: Vol. 71 No. 4 (2019)
- C. Manzo, Clinical practice guidelines for patients with polymyalgia rheumatica: the need for an active involvement of all stakeholder is still unmet , Reumatismo: Vol. 72 No. 2 (2020)
- N. Ughi, G.D. Sebastiani, R. Gerli, C. Salvarani, S. Parisi, A. Ariani, I. Prevete, M. Manara, F. Rumi, C.A. Scirè, A. Bortoluzzi, Reply to the Letter to the Editor: The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica , Reumatismo: Vol. 72 No. 2 (2020)
- F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano, Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study , Reumatismo: Vol. 72 No. 1 (2020)
- F. Ingegnoli, A. Manzo, F. Fantini, R. Caporali, C. Montecucco, N. Pipitone, C. Pitzalis, Role of chemokines in the pathogenesis of rheumatoid synovitis , Reumatismo: Vol. 54 No. 1 (2002)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
